COMBINAISON D'AGONISTES DE FXR
- 专利权人:
- NOVARTIS AG
- 发明人:
- LAFFITTE, BRYAN,BAUER, ANDREAS,MUELLER, PATRICK
- 申请号：
- CA3036760
- 公开号：
- CA3036760A1
- 申请日:
- 2017.09.12
- 申请国别(地区):
- CA
- 年份:
- 2018
- 代理人:
- 摘要：
- The invention provides pharmaceutical compositions comprising a farnesoid X receptor (FXR) agonist and another therapeutic agent, in particular for treating or preventing liver diseases or disorders.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- APPLICATION OF TRIACETHYL-3-HYDROXYPHENYLENADENOSINE FOR THE PRODUCTION OF A PHARMACEUTICAL MEDICINE FOR THE PREVENTION OR TREATMENT OF A NON-ALCOHOLIC LIVER LIVER DISEASE DISEASE
- IMIDAZO[4,5-D]PYRIMIDINES, PROCEDES D'UTILISATION ET DE PREPARATION CORRESPONDANTS
- USE OF MITOCHONDRIALLY-ADDRESSED COMPOUNDS FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES
- 5 - fluoro substituted 1h pirazolopiridinas and its use
- АТТЕНУИРОВАННЫЕ ГРИППОЗНЫЕ ВЕКТОРЫ ДЛЯ ПРОФИЛАКТИКИ И/ИЛИ ЛЕЧЕНИЯ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ, А ТАКЖЕ ДЛЯ ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ
